Huvudsakliga offentliga loggar

Hoppa till navigering Hoppa till sök

Kombinerad visning av alla tillgängliga loggar för BryggarWiki. Du kan avgränsa sökningen och få färre träffar genom att ange typ av logg, användarnamn (skiftlägeskänsligt), eller berörd sida (också skiftlägeskänsligt).

Loggar
  • 14 oktober 2026 kl. 14.59 GlennGreig3 diskussion bidrag skapade sidan Central European Time, Or 1 P.m (Skapade sidan med '<br>INDIANAPOLIS, Oct. 4, 2018 /PRNewswire/ -- Results from a phase 2b clinical trial of Eli Lilly and Company's (NYSE: LLY) dual GIP and GLP-1 receptor agonist (GIP/GLP-1 RA, LY3298176) showed strong and clinically meaningful blood sugar reduction and weight loss in people with type 2 diabetes. The weekly dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor [https://oistinprojects.xyz/index.php/User:JudeSales213 MedicGLP] agonist integrates the ac...')
  • 9 oktober 2026 kl. 03.49 GlennGreig3 diskussion bidrag skapade sidan Albiglutide: A New GLP-1 Receptor Agonist For The Treatment Of Type 2 Diabetes (Skapade sidan med '<br>Objective: To review the pharmacology, pharmacokinetics, safety, and efficacy of albiglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA) in type 2 diabetes (T2D). Data sources: A MEDLINE search (1950-June 2014) was conducted using the keyword albiglutide. References were reviewed to identify additional sources. Study selection and data extraction: Articles evaluating pharmacokinetics, pharmacodynamics, safety, or efficacy of albiglutide were included. Data...')
  • 28 augusti 2026 kl. 12.04 GlennGreig3 diskussion bidrag skapade sidan Osmolality Testing And Certification (Skapade sidan med '<br>Products that meet strict testing and [http://flipy.cz/index.php?title=Case_Study:_The_Efficacy_Of_GLP-1_Agonists_In_Weight_Loss_Management MedicGLP Formula] evaluation criteria can become THE OSMOLab℠ CERTIFIED. Osmolality is a measurement of materials in a solution. Technically speaking, that measurement is expressed in the scientific standard of osmoles of solute particles per kilogram of solvent. Our lab measures the osmolality of the testable liquids that con...')
  • 28 augusti 2026 kl. 04.35 GlennGreig3 diskussion bidrag skapade sidan Insulin Dose Adjustments With Add-on Glucagon-like Peptide-1 Receptor (GLP-1R) Agonists In Clinical Practice (Skapade sidan med '<br>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are gaining ground as therapeutic modalities in combination with insulin in patients with type 2 diabetes mellitus. Exploiting the multiple benefits of incretin-based therapies in certain patient populations, especially in those who would benefit most from potential weight loss or prevention of body weight gain, has provided a valuable add-on option in diabetes management. However, caution needs to be exercised whe...')
  • 28 augusti 2026 kl. 04.35 GlennGreig3 diskussion bidrag skapade sidan Användare:GlennGreig3 (Skapade sidan med 'My name is Maximo and I am studying Architecture and Biochemistry at Dittersbach / Germany.<br><br>Feel free to visit my blog :: daily wellness supplement ([http://yunseuljae.com/gnu5/bbs/board.php?bo_table=free&wr_id=337096 relevant web site])')
  • 13 augusti 2026 kl. 13.44 Användarkonto GlennGreig3 diskussion bidrag har skapats